Fermion, a subsidiary of Orion Corporation, is a CDMO based in Espoo, Finland, that manufactures and markets APIs. Together with their parent company, they provide an integrated solution encompassing a portfolio of over 30 generic APIs and 10 new molecular entities (NCEs). Fermion offers synthesis and process development, analytical development, IND/IMPD support, and commercial manufacturing to support clients from clinical phase I through commercialization.
